New Norovirus Genotype Drove Most Outbreaks in 2024-2025 Season
A research letter from CDC’s Emerging Infectious Diseases has identified the increasing prevalence of a different type of norovirus than usual in the U.S.
Specifically, GII.17 cases and outbreaks were up during the 2023-24 season. However, during 2011-2024, “GII.4 viruses have caused >50% of U.S. outbreaks each season.” During the 2022-23 season, “GII.17 accounted for 7.5% and GII.4 for 48.9% of all outbreaks. The next season (2023-24), the percentage of GII.17 outbreaks increased to 34.3%, whereas GII.4 outbreaks declined to 27.7%. By the 2024-25 season, GII.17 outbreaks had increased markedly to 75.4%, whereas GII.4 outbreaks further decreased to 10.7%. In addition, during 2022-23 and 2023-24, seasonality was primarily driven by GII.4 viruses, showing peak activity in February 2023 and March 2024, whereas during the 2024-25 season, norovirus peaked in January 2025.”
The percentage of GII.17 outbreaks (47.4%) overtook the percentage of GII.4 outbreaks (23.7%) in April 2024, and “from May 2024 through March 2025, GII.17 accounted for >50% of all outbreaks each month.”
These data “highlight a substantial shift in genotype distribution of norovirus outbreaks in the U.S. from 2022 to 2025, with GII.17 emerging as the predominant genotype. That shift coincides with a notable decline in GII.4, which has traditionally been the leading cause of U.S. outbreaks.” Additionally, in 2024-25, the onset of the norovirus season was in early October 2024, when it typically has begun in early December each season.
About the Author
Matt MacKenzieMatt MacKenzie
Associate Editor
Matt MacKenzie is Senior Staff Writer and Associate Editor of Healthcare Purchasing News (HPN), where he leads daily news coverage and contributes in-depth features on healthcare supply chain, sterile processing, infection prevention and clinical operations. Through industry reporting and expert interviews, he examines the trends, technologies and operational challenges shaping healthcare purchasing and patient care.
Related
norovirus
influenza_2